Topic Name

Message

If ARUP Consult does not answer your test selection and interpretation questions, or if you would like to suggest ways to improve content or usability, please send a message to the Consult editorial staff.

Please do not include any patient-specific or personal health information (PHI) in your message.

Email Address

An email address is not required, but providing one allows the ARUP Consult editorial staff to respond directly. ARUP will only use your email address to respond to your feedback. See the ARUP privacy policy for more information regarding email use.

CAPTCHA

What code is in the image?

Enter the characters shown in the image.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

CPIC Guideline for Atazanavir and UGT1A1

Clinical Pharmacogenetics Implementation Consortium. CPIC guideline for atazanavir and UGT1A1. Updated Nov 2017; accessed Jul 2022.

Feedback

CPIC Guideline for Atazanavir and UGT1A1

What links here